Wedbush Raises Price Target on L Brands (LB) Following 2Q15 Earnings

Mizuho Securities Cuts Price Target on L Brands (LB) Reflecting a Multiple Contraction in the Retail Space Following 2Q

Mizuho Securities maintained a Buy rating on L Brands (NYSE: LB), and cut the price target to $100.00 (from $108.00), reflecting a multiple contraction in the retail space following 2Q. 2Q EPS of $0.68 vs. $0.63 LY was in-line with consensus $0.68. LB guides 3Q EPS of $0.40-0.45. Analyst Betty... More

Streetinsider.com's Hot Lunchtime Reads 8/20: (UNFI) (LB) (IQNT) (VRX)

The following is a list of notable articles to help get you through the lunch hour:Piper Jaffray remains Bullish on United Natural Foods (UNFI) Following Preliminary Q4 Earnings and FY16 Initial Guidance ->... More

Stifel Affirms L Brands (LB) at 'Hold'; Q3 Outlook Like, May be Case of 'Under Promise, Over Deliver'

Stifel affirms L Brands (NYSE: LB) at Hold following the company's Q2 results, which were reported after markets closed Wednesday.

Analyst Richard Jaffe noted that EPS of $0.68 was flat with estimates even considering a $0.02 per share negative foreign currency impact. The analyst continued, Management... More

Pre-Open Stock Movers 08/20: (PTN) (AGTC) (PERY) (NTAP) Higher; (ANFI) (JMEI) (MOMO) Lower (more...)

Palatin Technologies Inc. (NYSE: PTN) 13% HIGHER; Valeant acquires rival Sprout

Amira Nature Foods (NYSE: ANFI) 12% LOWER; said it terminated Deloitte Haskins & Sells LLP as its independent registered public accounting firm.

Applied Genetic Technologies (NASDAQ: AGTC) 9.6% HIGHER; announced that its collaboration with Biogen (Nasdaq: BIIB), first announced on July 2, 2015 is effective, and Biogen's equity investment in AGTC has closed, following the expiration of the... More

UBS Cuts Price Target on L Brands (LB) to $100 Following 2Q In-Line EPS

UBS maintained a Buy rating on L Brands (NYSE: LB), and cut the price target to $100.00 (from $106.00), following the company's 2Q15 earnings results. LB reported EPS of $0.68 comming in at the high-end of recently raised guidance of $0.66-0.68, and in-line with Street's $0.68. Analyst Michael Binetti continues to view LB as a consistent, long-term EPS delivery story with multiple topline and margin expansion opportunities.

Binetti commented, "There have been some recent concerns... More

Cowen Remains Bullish on L Brands (LB) Following 2Q Earnings

Cowen maintained an Outperform rating and $100.00 price target on L Brands (NYSE: LB) following the company's 2Q15 earnings report. LB reported EPS of $0.68, in line the Street estimates, and versus mgmt's guidance of $0.66-$0.68. Management raised their outlook for 2015 EPS to be in the... More

After-Hours Stock Movers 08/19: (ACTG) (KEYS) (NTAP) Higher; (ANFI) (SMTC) (PLKI) Lower (more...)

Amira Nature Foods (NYSE: ANFI) 12% LOWER; said it terminated Deloitte Haskins & Sells LLP as its independent registered public accounting firm.

Applied Genetic Technologies (NASDAQ: AGTC) 9.6% HIGHER; announced that its collaboration with Biogen (Nasdaq: BIIB), first announced on July 2, 2015 is effective, and Biogen's equity investment in AGTC has closed, following the expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the satisfaction of other customary... More

L Brands (LB) Reports In-Line Q2 EPS; Issues Light Q3 EPS Outlook

L Brands (NYSE: LB) reported Q2 EPS of $0.68, in-line with the analyst estimate of $0.68. Revenue for the quarter came in at $2.77 billion versus the consensus estimate of $2.8 billion.

L Brands sees FY2015 EPS of $3.58-$3.73, versus the consensus of $3.73.

L Brands sees Q3... More